{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:46:10Z","timestamp":1794901570244,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Metabolic Syndrome (MetS) significantly increases the risk of cardiovascular disease (CVD), with central obesity and insulin resistance as major contributors. The TyG-ABSI index is a newly proposed composite measure that combines the TyG index and ABSI, aiming to assess both insulin resistance and central obesity simultaneously. Previous studies have shown that TyG-ABSI has potential in predicting cardiovascular mortality, but its applicability in MetS populations remains unclear. This study aims to explore the association between TyG-ABSI and cardiovascular events in individuals with MetS and compare its predictive value with the traditional TyG index in this specific population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Participants from the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2018 were selected, with all data weighted for sample design, clustering, and stratification to ensure national representativeness. Associations between TyG-ABSI and other TyG indices with cardiovascular mortality and all-cause mortality were assessed using weighted Cox proportional hazards models; CVD prevalence was analyzed using weighted logistic regression models. Additional analyses included Kaplan\u2013Meier survival curves and restricted cubic spline regression. Model performance was compared between TyG-ABSI, TyG, and its derived indices using ROC curves, NRI, IDI, and DCA. E-value, subgroup analyses, and competing risks models were conducted to assess robustness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study analyzed data from 12,813 individuals with metabolic syndrome in the NHANES cohort to systematically compare the performance of TyG-ABSI and other TyG-related indices in assessing CVD and mortality. The results revealed significant associations between TyG-ABSI and CVD, cardiovascular mortality, and all-cause mortality. Specifically, for each 1-unit increase in TyG-ABSI, the risk of CVD increased by 28%, cardiovascular mortality by 25%, and all-cause mortality by 28%. These associations showed a dose\u2013response relationship in stratified analyses based on tertiles, and TyG-ABSI outperformed the traditional TyG index in overall analysis. Compared to other TyG-related indices, TyG-ABSI demonstrated superior predictive performance in metrics such as the ROC curve, NRI, and DCA. Further analyses, including competing risks models, E-value estimation, and RCS modeling, confirmed the robustness of these associations. Subgroup analyses also supported the stability of TyG-ABSI, with limited interaction effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study highlights the value of TyG-ABSI in assessing cardiovascular disease and mortality risk in populations with MetS, providing new evidence for medical practice and public health interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02902-6","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:34:54Z","timestamp":1755776094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES"],"prefix":"10.1186","volume":"24","author":[{"given":"Xin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"16","key":"2902_CR1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"key":"2902_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijcard.2006.06.062","volume":"119","author":"TO Cheng","year":"2006","unstructured":"Cheng TO. Cardiac syndrome X versus metabolic syndrome X. Int J Cardiol. 2006;119:137\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2006.06.062.","journal-title":"Int J Cardiol"},{"key":"2902_CR3","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.5888\/pcd14.160287","volume":"14","author":"JX Moore","year":"2017","unstructured":"Moore JX, Chaudhary N, Akinyemiju T. Peer reviewed: metabolic syndrome prevalence by race\/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988\u20132012. Prev Chronic Dis. 2017;14:E24. https:\/\/doi.org\/10.5888\/pcd14.160287.","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"2902_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/dc07-1030","volume":"31","author":"ES Ford","year":"2008","unstructured":"Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care. 2008;31(3):587\u20139. https:\/\/doi.org\/10.2337\/dc07-1030.","journal-title":"Diabetes Care"},{"issue":"3","key":"2902_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/0975-3583.98895","volume":"3","author":"DS Prasad","year":"2012","unstructured":"Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban eastern India. J Cardiovasc Dis Res. 2012;3(3):204\u201311. https:\/\/doi.org\/10.4103\/0975-3583.98895.","journal-title":"J Cardiovasc Dis Res"},{"issue":"5","key":"2902_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.recesp.2013.08.014","volume":"67","author":"P Guallar-Castill\u00f3n","year":"2014","unstructured":"Guallar-Castill\u00f3n P, P\u00e9rez RF, L\u00f3pez-Garc\u00eda E, Banegas JR, Guti\u00e9rrez-Fisac JL, Alonso J, et al. Magnitude and management of metabolic syndrome in Spain in 2008\u20132010: the ENRICA study. Rev Esp Cardiol. 2014;67(5):367\u201373. https:\/\/doi.org\/10.1016\/j.recesp.2013.08.014.","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"2902_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/dc08-1195","volume":"32","author":"K Faerch","year":"2009","unstructured":"Faerch K, Vaag A, Holst JJ, Hansen T, J\u00f8rgensen T, Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2009;32(3):439\u201344. https:\/\/doi.org\/10.2337\/dc08-1195.","journal-title":"Diabetes Care"},{"issue":"4","key":"2902_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773\u201395. https:\/\/doi.org\/10.2337\/db09-9028.","journal-title":"Diabetes"},{"issue":"4","key":"2902_CR9","first-page":"201","volume":"47","author":"GM Reaven","year":"2005","unstructured":"Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005;47(4):201\u201310.","journal-title":"Panminerva Med"},{"key":"2902_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020786","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23020786.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2902_CR11","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351. https:\/\/doi.org\/10.1210\/jc.2010-0288.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2902_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride glucose (TyG) index: a surrogate biomarker of insulin resistance. JPMA J Pak Med Assoc. 2022;72(5):986\u20138. https:\/\/doi.org\/10.47391\/JPMA.22-63.","journal-title":"JPMA J Pak Med Assoc"},{"issue":"1","key":"2902_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang Y, Chen S, Xiang H, Ouyang J, Liu H, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80. https:\/\/doi.org\/10.1186\/s12933-024-02152-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134. https:\/\/doi.org\/10.1186\/s12933-024-02215-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2902_CR16","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.1371\/journal.pone.0039504","volume":"7","author":"NY Krakauer","year":"2012","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7):e39504.","journal-title":"PLoS ONE"},{"issue":"1","key":"2902_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12933-025-02604-z","volume":"24","author":"HM He","year":"2025","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Fu SJ, Li N, Han YR, Gao YX, Zheng JG. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24(1):69. https:\/\/doi.org\/10.1186\/s12933-025-02604-z.","journal-title":"Cardiovasc Diabetol"},{"key":"2902_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/27697061.2025.2475876","volume":"20","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wei Z, Wang L, Zhang G, Yang G, Yu J, Wu Q, Liu J. Association of triglyceride-glucose-related obesity indices with all-cause and cardiovascular mortality among individuals with hyperuricemia: a retrospective cohort study. J Am Nutr Assoc. 2025;20:1\u201310. https:\/\/doi.org\/10.1080\/27697061.2025.2475876.","journal-title":"J Am Nutr Assoc"},{"key":"2902_CR19","doi-asserted-by":"publisher","first-page":"160096","DOI":"10.1038\/sdata.2016.96","volume":"3","author":"CJ Patel","year":"2016","unstructured":"Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, et al. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci Data. 2016;3:160096. https:\/\/doi.org\/10.1038\/sdata.2016.96.","journal-title":"Sci Data"},{"key":"2902_CR20","unstructured":"National Center for Health Statistics (NCHS). Centers for Disease Control and Prevention NCHS Research Ethics Review Board (ERB) approval. 2023. Available from: https:\/\/www.cdc.gov\/nchs\/nhanes\/irba98.htm."},{"issue":"19","key":"2902_CR21","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"JI Cleeman","year":"2001","unstructured":"Cleeman JI. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","journal-title":"JAMA"},{"issue":"1","key":"2902_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","volume":"43","author":"SL Samson","year":"2014","unstructured":"Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1\u201323. https:\/\/doi.org\/10.1016\/j.ecl.2013.09.009.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9468","key":"2902_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(05)66378-7.","journal-title":"Lancet"},{"issue":"2","key":"2902_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https:\/\/doi.org\/10.1007\/s11906-018-0812-z.","journal-title":"Curr Hypertens Rep"},{"issue":"8","key":"2902_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jacc.2013.05.064","volume":"62","author":"H Beltr\u00e1n-S\u00e1nchez","year":"2013","unstructured":"Beltr\u00e1n-S\u00e1nchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999\u20132010. J Am Coll Cardiol. 2013;62(8):697\u2013703. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.064.","journal-title":"J Am Coll Cardiol"},{"key":"2902_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijcard.2018.01.139","volume":"259","author":"D Shin","year":"2018","unstructured":"Shin D, Kongpakpaisarn K, Bohra C. Trends in the prevalence of metabolic syndrome and its components in the United States 2007\u20132014. Int J Cardiol. 2018;259:216\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2902_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12933-023-02113-x","volume":"23","author":"Z Ding","year":"2024","unstructured":"Ding Z, Ge M, Tan Y, Chen C, Hei Z. The triglyceride-glucose index: a novel predictor of stroke and all-cause mortality in liver transplantation recipients. Cardiovasc Diabetol. 2024;23(1):27. https:\/\/doi.org\/10.1186\/s12933-023-02113-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12933-022-01664-9","volume":"21","author":"F Yan","year":"2022","unstructured":"Yan F, Yan S, Wang J, Cui Y, Chen F, Fang F, et al. Association between triglyceride-glucose index and risk of cerebrovascular disease: systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):226. https:\/\/doi.org\/10.1186\/s12933-022-01664-9.","journal-title":"Cardiovasc Diabetol"},{"key":"2902_CR29","doi-asserted-by":"publisher","first-page":"1424881","DOI":"10.3389\/fnut.2024.1424881","volume":"11","author":"X Meng","year":"2024","unstructured":"Meng X, Wen H, Lian L. Association between triglyceride glucose-body mass index and obstructive sleep apnea: a study from NHANES 2015\u20132018. Front Nutr. 2024;11:1424881. https:\/\/doi.org\/10.3389\/fnut.2024.1424881.","journal-title":"Front Nutr"},{"key":"2902_CR30","doi-asserted-by":"publisher","first-page":"1362119","DOI":"10.3389\/fnut.2024.1362119","volume":"11","author":"H Jiang","year":"2024","unstructured":"Jiang H, Yang G, Chen J, Yuan S, Wu J, Zhang J, Zhang L, Yuan J, Lin J, Chen J, Yin Y. The correlation between selenium intake and lung function in asthmatic people: a cross-sectional study. Front Nutr. 2024;11:1362119. https:\/\/doi.org\/10.3389\/fnut.2024.1362119.","journal-title":"Front Nutr"},{"issue":"10","key":"2902_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/pds.5117","volume":"29","author":"X Zhang","year":"2020","unstructured":"Zhang X, Stamey JD, Mathur MB. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence. Pharmacoepidemiol Drug Saf. 2020;29(10):1219\u201327. https:\/\/doi.org\/10.1002\/pds.5117.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2902_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ije\/dyac018","volume":"51","author":"A Sj\u00f6lander","year":"2022","unstructured":"Sj\u00f6lander A, Greenland S. Are E-values too optimistic or too pessimistic? Both and neither! Int J Epidemiol. 2022;51(2):355\u201363. https:\/\/doi.org\/10.1093\/ije\/dyac018.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"2902_CR33","doi-asserted-by":"publisher","first-page":"e24049","DOI":"10.1002\/jcla.24049","volume":"35","author":"Z Xiao","year":"2021","unstructured":"Xiao Z, Gong R, Chen X, Xiao D, Luo S, Ji Y. Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: a cohort study. J Clin Lab Anal. 2021;35(12):e24049. https:\/\/doi.org\/10.1002\/jcla.24049.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2902_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171. https:\/\/doi.org\/10.1186\/s12933-024-02269-0.","journal-title":"Cardiovasc Diabetol"},{"key":"2902_CR35","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.2147\/COPD.S477268","volume":"19","author":"X Wang","year":"2024","unstructured":"Wang X, Cui X, Fan H, Hu T. Elevated triglyceride-glucose (TyG) index predicts poor clinical outcomes in critically ill AECOPD patients: a retrospective study. Int J Chron Obstruct Pulmon Dis. 2024;19:2217\u201328. https:\/\/doi.org\/10.2147\/COPD.S477268.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"2902_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12933-024-02310-2","volume":"23","author":"Q Gao","year":"2024","unstructured":"Gao Q, Luo F, Yu H, Lin Y, Xu R, Li P, Zhang Y, Liu J, Su L, Li Y. U-shaped association between triglyceride-glucose index and all-cause mortality among critically ill pediatrics: a population-based retrospective cohort study. Cardiovasc Diabetol. 2024;23(1):222. https:\/\/doi.org\/10.1186\/s12933-024-02310-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12877-024-05002-4","volume":"24","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liang S, Liu J, Man M, Si Y, Jia D, Li J, Tian X, Li L. Triglyceride-glucose index as a potential predictor for in-hospital mortality in critically ill patients with intracerebral hemorrhage: a multicenter, case-control study. BMC Geriatr. 2024;24(1):385. https:\/\/doi.org\/10.1186\/s12877-024-05002-4.","journal-title":"BMC Geriatr"},{"issue":"1","key":"2902_CR38","doi-asserted-by":"publisher","first-page":"24081","DOI":"10.1038\/s41598-024-75050-8","volume":"14","author":"J Lou","year":"2024","unstructured":"Lou J, Xiang Z, Zhu X, Fan Y, Song J, Cui S, Li J, Jin G, Huang N. A retrospective study utilizing the MIMIC-IV database to explore the potential association between triglyceride-glucose index and mortality in critically ill patients with sepsis. Sci Rep. 2024;14(1):24081. https:\/\/doi.org\/10.1038\/s41598-024-75050-8.","journal-title":"Sci Rep"},{"issue":"1","key":"2902_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride-glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320. https:\/\/doi.org\/10.1186\/s12933-023-02054-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, Liu L, Ming Z, Tao X, Li Y. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride-glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):262. https:\/\/doi.org\/10.1186\/s12933-024-02354-4.","journal-title":"Cardiovasc Diabetol"},{"key":"2902_CR42","doi-asserted-by":"publisher","first-page":"1471535","DOI":"10.3389\/fendo.2024.1471535","volume":"15","author":"D Zheng","year":"2024","unstructured":"Zheng D, Cai J, Xu S, Jiang S, Li C, Wang B. The association of triglyceride-glucose index and combined obesity indicators with chest pain and risk of cardiovascular disease in American population with pre-diabetes or diabetes. Front Endocrinol. 2024;15:1471535. https:\/\/doi.org\/10.3389\/fendo.2024.1471535.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2902_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose-related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134. https:\/\/doi.org\/10.1186\/s12933-024-02215-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2902_CR44","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951\u201368. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318093.","journal-title":"Circ Res"},{"key":"2902_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2019.153946","volume":"99","author":"JR Sowers","year":"2019","unstructured":"Sowers JR, Habibi J, Aroor AR, Yang Y, Lastra G, Hill MA, Whaley-Connell A, Jaisser F, Jia G. Epithelial sodium channels in endothelial cells mediate diet-induced endothelium stiffness and impaired vascular relaxation in obese female mice. Metabolism. 2019;99:57\u201366. https:\/\/doi.org\/10.1016\/j.metabol.2019.153946.","journal-title":"Metabolism"},{"key":"2902_CR46","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1113\/JP279376","volume":"599","author":"M Federico","year":"2021","unstructured":"Federico M, De la Fuente S, Palomeque J, Sheu SS. The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction. J Physiol. 2021;599:3477\u201393. https:\/\/doi.org\/10.1113\/JP279376.","journal-title":"J Physiol"},{"key":"2902_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"JA Kim","year":"2008","unstructured":"Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401\u201314. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.165472.","journal-title":"Circ Res"},{"key":"2902_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00424-021-02638-8","volume":"474","author":"HN de Las","year":"2022","unstructured":"de Las HN, Lahera V. Relevance of mitochondrial dysfunction in heart disease associated with insulin resistance conditions. Pflug Arch Eur J Phy. 2022;474:21\u201331. https:\/\/doi.org\/10.1007\/s00424-021-02638-8.","journal-title":"Pflug Arch Eur J Phy"},{"key":"2902_CR49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.tem.2011.05.001","volume":"22","author":"S Gray","year":"2011","unstructured":"Gray S, Kim JK. New insights into insulin resistance in the diabetic heart. Trends Endocrinol Metab. 2011;22:394\u2013403. https:\/\/doi.org\/10.1016\/j.tem.2011.05.001.","journal-title":"Trends Endocrinol Metab"},{"key":"2902_CR50","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GN, Kitsis RN, et al. Mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association. Circ Res. 2016;118:1960\u201391. https:\/\/doi.org\/10.1161\/RES.0000000000000104.","journal-title":"Circ Res"},{"key":"2902_CR51","doi-asserted-by":"publisher","first-page":"734","DOI":"10.18632\/aging.100505","volume":"4","author":"F Pintus","year":"2012","unstructured":"Pintus F, Floris G, Rufini A. Nutrient availability links mitochondria, apoptosis, and obesity. Aging. 2012;4:734\u201341. https:\/\/doi.org\/10.18632\/aging.100505.","journal-title":"Aging"},{"key":"2902_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2741\/4758","volume":"24","author":"RT Atawia","year":"2019","unstructured":"Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci Landmrk. 2019;24:890\u2013934. https:\/\/doi.org\/10.2741\/4758.","journal-title":"Front Biosci Landmrk"},{"issue":"1","key":"2902_CR53","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12933-025-02880-9","volume":"24","author":"YC Zhao","year":"2025","unstructured":"Zhao YC, Wu SQ, Li JK, Sun ZH, Zhang BK, Fu R, Yan M. Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):318. https:\/\/doi.org\/10.1186\/s12933-025-02880-9.","journal-title":"Cardiovasc Diabetol"},{"key":"2902_CR54","doi-asserted-by":"publisher","first-page":"119480","DOI":"10.1016\/j.jad.2025.119480","volume":"386","author":"PL Liu","year":"2025","unstructured":"Liu PL, Gao S, Zhang Y, Li J, Du J, Dong QL, Liu XR. Associations between the triglyceride-glucose index and its combined indices with sleep disorders and the mediating role of depressive symptoms: Results from two nationally representative population studies. J Affect Disord. 2025;386:119480. https:\/\/doi.org\/10.1016\/j.jad.2025.119480.","journal-title":"J Affect Disord"},{"issue":"1","key":"2902_CR55","doi-asserted-by":"publisher","first-page":"22637","DOI":"10.1038\/s41598-025-08133-9","volume":"15","author":"W Mi","year":"2025","unstructured":"Mi W, Hao YH, Wan MG, Zhang JL, Huang HM, Song CZ, He QJ, Fan NY, Yao X, Chen CY. Comparative study of triglyceride glucose index and coronary heart disease risk in middle aged and elderly Chinese and British populations. Sci Rep. 2025;15(1):22637. https:\/\/doi.org\/10.1038\/s41598-025-08133-9.","journal-title":"Sci Rep"},{"issue":"1","key":"2902_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12933-025-02770-0","volume":"24","author":"L Hu","year":"2025","unstructured":"Hu L, Li J, Tang Z, Gong P, Chang Z, Yang C, Ma T, Jiang S, Yang C, Zhang T. How does biological age acceleration mediate the associations of obesity with cardiovascular disease? Evidence from international multi-cohort studies. Cardiovasc Diabetol. 2025;24(1):209. https:\/\/doi.org\/10.1186\/s12933-025-02770-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2902_CR57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","volume":"24","author":"Y Yue","year":"2025","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K, Zhang Y. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24(1):301. https:\/\/doi.org\/10.1186\/s12933-025-02854-x.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02902-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:35:11Z","timestamp":1757478911000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02902-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2902"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02902-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}